Life after brain inflammation: new study probes hidden scars of rare disease
NCT ID NCT07158229
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study looks at the long-term social and emotional challenges faced by people who have had NMDA receptor encephalitis, a rare brain inflammation. Researchers will ask 30 adults to complete questionnaires about fatigue, anxiety, depression, sleep, and quality of life. The goal is to understand how the disease affects daily functioning and well-being years after the initial illness.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- What this could lead to
- If successful, this study could reveal how NMDA receptor encephalitis affects patients' daily lives long after the acute phase, guiding better support and rehabilitation.
- What could go wrong
- This is a small observational study with only 30 participants, so findings may not apply to all patients. It relies on questionnaires, not treatments, so no direct medical benefit is expected.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for NMDA RECEPTOR ANTIBODY ENCEPHALITIS are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Centre de référence des syndromes neurologies paranéoplasiques et encéphalites auto-immunes - Hôpital neurologiques Pierre WERTHEIMER - Groupement hospitalier Est - Hospices civiles de Lyon
RECRUITINGBron, 69500, France
More trials for these conditions
Other studies related to the condition(s) this trial covers.